Search

Your search keyword '"Abraham, Christopher"' showing total 240 results

Search Constraints

Start Over You searched for: Author "Abraham, Christopher" Remove constraint Author: "Abraham, Christopher"
240 results on '"Abraham, Christopher"'

Search Results

4. A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma

8. A Pilot Study of Simulation-Free Hippocampal-Avoidance Whole Brain Radiotherapy Using Diagnostic MRI-Based and Online Adaptive Planning

9. Impact of solid waste on groundwater quality in selected dumpsites in AkwaIbom State, Nigeria using resistivity and hydrochemical data

12. VA-Radiation Oncology Quality Surveillance Program

13. RADT-01. BASELINE HIPPOCAMPAL VOLUME AS A PREDICTOR OF NEUROCOGNITIVE CHANGES AFTER WBRT OR HA-WBRT: SECONDARY ANALYSIS OF NRG ONCOLOGY CC001

17. A pilot phase 1B study to evaluate tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wildtype glioblastoma

20. Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine

23. Clinical application of a template‐guided automated planning routine

24. 624 A phase I/II study evaluating the safety and efficacy of a novel long-acting interleukin-7, NT-I7, for patients with newly diagnosed high-grade gliomas after chemoradiotherapy

25. CTIM-10. A PHASE II STUDY OF RETIFANLIMAB (PD-1 INHIBITOR) IN COMBINATION WITH BEVACIZUMAB AND HYPOFRACTIONATED RADIOTHERAPY FOR RECURRENT GLIOBLASTOMA: NCT03532295

26. Association of Pretreatment Hippocampal Volume With Neurocognitive Function in Patients Treated With Hippocampal Avoidance Whole Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology/RTOG 0933

27. Neoadjuvant stereotactic radiosurgery for brain metastases: a new paradigm

28. Impact of solid waste on groundwater quality in selected dumpsites in AkwaIbom State, Nigeria using resistivity and hydrochemical data

29. SPCR-01 RAPIDPLAN HIPPOCAMPAL SPARING WHOLE BRAIN MODEL VERSION 2 - HOW FAR CAN WE REDUCE THE DOSE?

30. Preliminary results of a phase II study of retifanlimab (PD-1 inhibitor) plus or minus epacadostat (IDO1 inhibitor) in combination with bevacizumab and hypofractionated radiotherapy for recurrent glioblastoma: NCT03532295.

31. Clinical application of a template-guided automated planning routine.

34. Forum

35. Sequence stratigraphic study of X field in eastern offshore of Niger Delta, Nigeria

38. CTIM-07. A PHASE I/II STUDY EVALUATING THE SAFETY AND EFFICACY OF A NOVEL LONG-ACTING INTERLEUKIN-7, NT-I7, FOR PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMAS AFTER CHEMORADIOTHERAPY

39. 396 NT-I7, a long-acting interleukin-7, promotes expansion of CD8 T cells and NK cells and immune activation in patients with newly diagnosed high-grade gliomas after chemoradiation

40. A framework for evaluating edited cell libraries created by massively parallel genome engineering

41. Internal dose escalation associated with increased local control for melanoma brain metastases treated with stereotactic radiosurgery

43. Safety and efficacy study of retifanlimab and epacadostat in combination with radiation and bevacizumab in patients with recurrent glioblastoma.

44. A phase I/II study to evaluate the safety and efficacy of a novel long-acting interleukin-7, NT-I7, for patients with newly diagnosed high-grade gliomas after chemoradiotherapy: The interim result of the phase I data.

46. Dosimetric predictors of symptomatic radiation necrosis after five-fraction radiosurgery for brain metastases

49. Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma

Catalog

Books, media, physical & digital resources